Format

Send to

Choose Destination
Curr Osteoporos Rep. 2013 Dec;11(4):305-10. doi: 10.1007/s11914-013-0180-1.

Osteoporosis after stem cell transplantation.

Author information

1
Division of Hematology, Oncology and Transplantation, University of Minnesota, 420 Delaware St, SE, Minneapolis, MN, 55455, USA, bmcclune@umn.edu.

Abstract

With long-term survival for recipients of autologous and allogeneic hematopoietic cell transplantation (HCT) increasing, the recognition of late complications such as decreased bone mineral density leading to osteoporosis (OP) has also increased. With an incidence that is reported to affect as many 50 % of allo HCT recipients, studies continue to mount supporting the need and success in treatment of this HCT complication. In this review, we highlight the major pathological mechanisms behind the development of OP, its diagnosis, and the literature supporting consensus treatment recommendations while noting areas of uncertainty that need further research.

PMID:
24202854
DOI:
10.1007/s11914-013-0180-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center